The OTC is Free-for-all, especially the cannabis sector. Unfortunately Marimed is not considered a “big player” yet and they also have a good amount of O/S which leaves them a prime target for MM’s to manipulate their stock price. This kind of stock behavior will last until either Marimed becomes a contender or the government legalizes cannabis. Don’t rely on the latter
Market Data 
Markets 
AI
